Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Abraham

Showing results (601-610 of 932) with videos related to

Pageof 94
Sort By:
Cardiorenal Medicine|June 27, 2024
Long-Term Renal Function with Cardiac Contractility Modulation TherapyGoekhan Yuecel, Babak Yazdani, Kristin Schreiner, et al.
European Heart Journal|February 21, 2007
Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registryMihai Gheorghiade, William T Abraham, Nancy M Albert, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 22, 2013
Endoscopic ultrasonography--a sensitive tool in the preoperative localization of insulinomaA J Joseph, Nitin Kapoor, Ebby G Simon, et al.
Journal of the American College of Cardiology|December 20, 2005
Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study programAngel R León, William T Abraham, Anne B Curtis, et al.
Circulation|October 28, 2009
Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failureMartin St John Sutton, Stefano Ghio, Ted Plappert, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 9, 2008
Worldwide surgical experience with the Paracor HeartNet cardiac restraint deviceCharles T Klodell, Juan M Aranda, David C McGiffin, et al.
Cardiovascular Drugs and Therapy|May 1, 1997
Second- and third-generation beta-blocking drugs in chronic heart failureM R Bristow, W T Abraham, T Yoshikawa, et al.
Journal of Analytical Toxicology|October 31, 2009
Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humansTsadik T Abraham, Allan J Barnes, Ross H Lowe, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|September 28, 2017
The Utility of a Wireless Implantable Hemodynamic Monitoring System in Patients Requiring Mechanical Circulatory SupportDavid S Feldman, Nader Moazami, Philip B Adamson, et al.
Circulation|October 15, 1995
Cardiac beta-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damageM White, R J Wiechmann, R L Roden, et al.
Pageof 94

Showing results (601-610 of 932) with videos related to

Sort By:
Pageof 94
Cardiorenal Medicine|June 27, 2024
Long-Term Renal Function with Cardiac Contractility Modulation TherapyGoekhan Yuecel, Babak Yazdani, Kristin Schreiner, et al.
European Heart Journal|February 21, 2007
Relationship between admission serum sodium concentration and clinical outcomes in patients hospitalized for heart failure: an analysis from the OPTIMIZE-HF registryMihai Gheorghiade, William T Abraham, Nancy M Albert, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|February 22, 2013
Endoscopic ultrasonography--a sensitive tool in the preoperative localization of insulinomaA J Joseph, Nitin Kapoor, Ebby G Simon, et al.
Journal of the American College of Cardiology|December 20, 2005
Safety of transvenous cardiac resynchronization system implantation in patients with chronic heart failure: combined results of over 2,000 patients from a multicenter study programAngel R León, William T Abraham, Anne B Curtis, et al.
Circulation|October 28, 2009
Cardiac resynchronization induces major structural and functional reverse remodeling in patients with New York Heart Association class I/II heart failureMartin St John Sutton, Stefano Ghio, Ted Plappert, et al.
The Journal of Thoracic and Cardiovascular Surgery|January 9, 2008
Worldwide surgical experience with the Paracor HeartNet cardiac restraint deviceCharles T Klodell, Juan M Aranda, David C McGiffin, et al.
Cardiovascular Drugs and Therapy|May 1, 1997
Second- and third-generation beta-blocking drugs in chronic heart failureM R Bristow, W T Abraham, T Yoshikawa, et al.
Journal of Analytical Toxicology|October 31, 2009
Urinary MDMA, MDA, HMMA, and HMA excretion following controlled MDMA administration to humansTsadik T Abraham, Allan J Barnes, Ross H Lowe, et al.
ASAIO Journal (American Society for Artificial Internal Organs : 1992)|September 28, 2017
The Utility of a Wireless Implantable Hemodynamic Monitoring System in Patients Requiring Mechanical Circulatory SupportDavid S Feldman, Nader Moazami, Philip B Adamson, et al.
Circulation|October 15, 1995
Cardiac beta-adrenergic neuroeffector systems in acute myocardial dysfunction related to brain injury. Evidence for catecholamine-mediated myocardial damageM White, R J Wiechmann, R L Roden, et al.
Pageof 94